mRNA vaccines deliver genetic instructions that cells use to produce a harmless piece of a pathogen. The immune system learns to recognize that protein and builds memory responses.
Key engineering challenges include stabilizing the mRNA, delivering it into cells, and managing immune activation so it is strong enough to protect without causing excessive inflammation.
Beyond infectious disease, researchers are exploring mRNA platforms for personalized cancer vaccines and rapid-response vaccines for emerging outbreaks.